Total Knee Arthroplasty (Postoperative Pain) Clinical Trial
— tDCS-CBIOfficial title:
tDCS Combined With a Brief Cognitive Intervention to Reduce Perioperative Pain and Opioid Requirements in Veterans
The purpose of this study is to determine whether a new medical technology can help reduce post-operative total knee or hip pain when combined with a Cognitive-Behavioral intervention (CBI). This new medical technology, is called transcranial direct current stimulation (tDCS), it uses a very small amount of electricity to temporarily stimulate specific areas of the brain thought to be involved in pain reduction. The electrical current passes through the skin, scalp, hair, and skull and requires no additional medication, sedation, or needles. This study will investigate the effects of tDCS, the Cognitive-Behavioral (CB) intervention and their combination on pain among veterans following total knee arthroplasty (TKA) or total hip arthroplasty (THA). The Veteran may benefit in the form of decreased pain and opioid requirements following knee or hip replacement surgery. However, benefit is only likely if Veterans are randomized to one of the 3 (out of 4) groups. This study hopes to determine the effects of these interventions and combined effect on post-operative pain, opioid use and functioning during the 48-hour post-operative period following a total knee or hip replacement.
| Status | Recruiting |
| Enrollment | 132 |
| Est. completion date | July 31, 2026 |
| Est. primary completion date | January 1, 2026 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 90 Years |
| Eligibility | Inclusion Criteria: Participants will be 120 patients (132 recruited to account for 10% drop-out rate) undergoing TKA or THA surgery at the Ralph H. Johnson VAMC in Charleston SC. - Mentally capable of reading, writing, giving consent, and following instructions - Cleared for, and scheduled for unilateral TKA or THA surgery - Able to hear CB intervention and understand educational materials through headphones in English Exclusion Criteria: - implanted medical devices above the waist - pregnant - history of seizures - allergic to latex rubber - psychiatric conditions except for depression and/or anxiety disorders (commonly seen in this population). |
| Country | Name | City | State |
|---|---|---|---|
| United States | Ralph H. Johnson VA Medical Center, Charleston, SC | Charleston | South Carolina |
| Lead Sponsor | Collaborator |
|---|---|
| VA Office of Research and Development |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | postoperative opioid pain medication use | Patient controlled analgesic medication usage (the morphine equivalent dose (MED); mg of morphine) during the acute 48-hour post-operative period following total knee arthroplasty (TKA) or total hip arthroplasty (THA). | 48 hours | |
| Secondary | Long term outcomes of patient reported pain ratings | long-term outcomes of post-operative tDCS and a cognitive-behavioral intervention on pain rating assessed using a visual analog scale. | 1 month | |
| Secondary | Long term outcomes of patient reported pain ratings | long-term outcomes of post-operative tDCS and a cognitive-behavioral intervention on pain rating assessed using a visual analog scale (minimum value =0, no pain at all; maximum value =10, worst pain imaginable). | 3 months | |
| Secondary | Long term outcomes of patient reported pain ratings | long-term outcomes of post-operative tDCS and a cognitive-behavioral intervention on pain rating assessed using a visual analog scale (minimum value =0, no pain at all; maximum value =10, worst pain imaginable). | 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02241967 -
Dose Dependent Effects of tDCS on Post-Operative Pain
|
Phase 1 |